Comprehensive Analysis of Peritoneal Metastasis Sequencing Data to Identify LINC00924 as a Prognostic Biomarker in Gastric Cancer

References

• Alyami M, Hubner M, Grass F, et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019;20(7):e368–e377. doi:10.1016/S1470-2045(19)30318-331267971
   PubMed Web of Science ®Google Scholar
• Bonnot PE, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37(23):2028–2040. doi:10.1200/JCO.18.0168831084544
   PubMed Web of Science ®Google Scholar
• Nair L, Chung H, Basu U. Regulation of long non-coding RNAs and genome dynamics by the RNA surveillance machinery. Nat Rev Mol Cell Biol. 2020;21(3):123–136. doi:10.1038/s41580-019-0209-032020081
   PubMed Web of Science ®Google Scholar
• Srirangam Nadhamuni V, Korbonits M. Novel insights into pituitary tumorigenesis: genetic and epigenetic mechanisms. Endocr Rev. 2020;41(6).
   PubMed Web of Science ®Google Scholar
• Wang CJ, Zhu CC, Xu J, et al. The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer. 2019;18(1):115. doi:10.1186/s12943-019-1032-031272462
   PubMed Web of Science ®Google Scholar
• Zhuo W, Liu Y, Li S, et al. Long noncoding RNA GMAN, up-regulated in gastric cancer tissues, is associated with metastasis in patients and promotes translation of ephrin A1 by competitively binding GMAN-AS. Gastroenterology. 2019;156(3):676–691 e611. doi:10.1053/j.gastro.2018.10.05430445010
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhang J, Hou L, et al. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway. J Exp Clin Cancer Res. 2017;36(1):194.29282102
   PubMed Web of Science ®Google Scholar
• Wu Q, Ma J, Wei J, Meng W, Wang Y, Shi M. lncRNA SNHG11 promotes gastric cancer progression by activating the wnt/beta-catenin pathway and oncogenic autophagy. Mol Ther. 2021;29(3):1258–1278. doi:10.1016/j.ymthe.2020.10.01133068778
   PubMed Web of Science ®Google Scholar
• Kim JM, Chen DS. Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure). Ann Oncol. 2016;27(8):1492–1504. doi:10.1093/annonc/mdw21727207108
   PubMed Web of Science ®Google Scholar
• Li Y, Jiang T, Zhou W, et al. Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers. Nat Commun. 2020;11(1):1000. doi:10.1038/s41467-020-14802-232081859
   PubMed Web of Science ®Google Scholar
• Zhao L, Liu Y, Zhang J, Liu Y, Qi Q. LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint. Cell Death Dis. 2019;10(10):731. doi:10.1038/s41419-019-1886-531570691
   PubMed Web of Science ®Google Scholar
• Gil Del Alcazar CR, Aleckovic M, Polyak K. Immune escape during breast tumor progression. Cancer Immunol Res. 2020;8(4):422–427. doi:10.1158/2326-6066.CIR-19-078632238387
   PubMed Web of Science ®Google Scholar
• Thibault B, Castells M, Delord JP, Couderc B. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition. Cancer Metastasis Rev. 2014;33(1):17–39.24357056
   PubMed Web of Science ®Google Scholar
• Yang W, Yang C, Luo J, Wei Y, Wang W, Zhong Y. Adiponectin promotes preadipocyte differentiation via the PPARgamma pathway. Mol Med Rep. 2018;17(1):428–435. doi:10.3892/mmr.2017.788129115433
   PubMed Web of Science ®Google Scholar
• Ladanyi A, Mukherjee A, Kenny HA, et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene. 2018;37(17):2285–2301. doi:10.1038/s41388-017-0093-z29398710
   PubMed Web of Science ®Google Scholar
• Zheng Y, Xu Q, Liu M, et al. lnCAR: a comprehensive resource for lncRNAs from cancer arrays. Cancer Res. 2019;79(8):2076–2083. doi:10.1158/0008-5472.CAN-18-216930786995
   PubMed Web of Science ®Google Scholar
• Wu P, Heins ZJ, Muller JT, et al. Integration and analysis of CPTAC proteomics data in the context of cancer genomics in the cBioPortal. Mol Cell Proteomics. 2019;18(9):1893–1898. doi:10.1074/mcp.TIR119.00167331308250
   PubMed Web of Science ®Google Scholar
• Huang M, Narita S, Inoue T, et al. Fatty acid binding protein 4 enhances prostate cancer progression by upregulating matrix metalloproteinases and stromal cell cytokine production. Oncotarget. 2017;8(67):111780–111794. doi:10.18632/oncotarget.2290829340091
   PubMedGoogle Scholar
• Tan Y, Lin K, Zhao Y, et al. Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming. Theranostics. 2018;8(19):5452–5468. doi:10.7150/thno.2821930555557
   PubMed Web of Science ®Google Scholar
• He JY, Wei XH, Li SJ, et al. Adipocyte-derived IL-6 and leptin promote breast cancer metastasis via upregulation of Lysyl hydroxylase-2 expression. Cell Commun Signal. 2018;16(1):100. doi:10.1186/s12964-018-0309-z30563531
   PubMed Web of Science ®Google Scholar
• Lin X, Dinglin X, Cao S, et al. Enhancer-driven lncRNA BDNF-AS induces endocrine resistance and malignant progression of breast cancer through the RNH1/TRIM21/mTOR cascade. Cell Rep. 2020;31(10):107753. doi:10.1016/j.celrep.2020.10775332521278
   PubMed Web of Science ®Google Scholar
• Fan Y, Li H, Yu Z, et al. Long non-coding RNA FGD5-AS1 promotes non-small cell lung cancer cell proliferation through sponging hsa-miR-107 to up-regulate FGFRL1. Biosci Rep. 2020;40(1). doi:10.1042/BSR20193309
   Web of Science ®Google Scholar
• Fu J, Cai H, Wu Y, Fang S, Wang D. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis. Gene. 2020;755:144886. doi:10.1016/j.gene.2020.14488632534055
   PubMed Web of Science ®Google Scholar
• Gao J, Zhang Z, Su H, Zong L, Li Y. Long noncoding RNA FGD5-AS1 acts as a competing endogenous RNA on microRNA-383 to enhance the malignant characteristics of esophageal squamous cell carcinoma by increasing SP1 expression. Cancer Manag Res. 2020;12:2265–2278. doi:10.2147/CMAR.S23657632273764
   PubMed Web of Science ®Google Scholar
• Gao Y, Xie M, Guo Y, Yang Q, Hu S, Li Z. Long non-coding RNA FGD5-AS1 regulates cancer cell proliferation and chemoresistance in gastric cancer through miR-153-3p/CITED2 axis. Front Genet. 2020;11:715. doi:10.3389/fgene.2020.0071532849774
   PubMed Web of Science ®Google Scholar
• Qiao F, Gong P, Song Y, et al. Downregulated PITX1 modulated by MiR-19a-3p promotes cell malignancy and predicts a poor prognosis of gastric cancer by affecting transcriptionally activated PDCD5. Cell Physiol Biochem. 2018;46(6):2215–2231. doi:10.1159/00048959029734189
   PubMedGoogle Scholar
• Stanulla M, Cave H, Moorman AV. IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker? Blood. 2020;135(4):252–260. doi:10.1182/blood.201900081331821407
   PubMed Web of Science ®Google Scholar
• Kim TH, Jo SH, Choi H, et al. Identification of Creb3l4 as an essential negative regulator of adipogenesis. Cell Death Dis. 2014;5:e1527. doi:10.1038/cddis.2014.49025412305
   PubMed Web of Science ®Google Scholar
• Hollern DP, Swiatnicki MR, Rennhack JP, et al. E2F1 drives breast cancer metastasis by regulating the target gene FGF13 and altering cell migration. Sci Rep. 2019;9(1):10718. doi:10.1038/s41598-019-47218-031341204
   PubMed Web of Science ®Google Scholar
• Garrido F, Aptsiauri N. Cancer immune escape: MHC expression in primary tumours versus metastases. Immunology. 2019;158(4):255–266. doi:10.1111/imm.1311431509607
   PubMed Web of Science ®Google Scholar
• Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252–264. doi:10.1038/nrc323922437870
   PubMed Web of Science ®Google Scholar
• Borst J, Ahrends T, Babala N, Melief CJM, Kastenmuller W. CD4(+) T cell help in cancer immunology and immunotherapy. Nat Rev Immunol. 2018;18(10):635–647. doi:10.1038/s41577-018-0044-030057419
   PubMed Web of Science ®Google Scholar
• Tian X, Shen H, Li Z, Wang T, Wang S. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment. J Hematol Oncol. 2019;12(1):84. doi:10.1186/s13045-019-0772-z31438991
   PubMed Web of Science ®Google Scholar